Review
Accepted on 13 Oct 2025
Promoting Immune Defensive Responses of Epithelial Cells in Airway Disease
Frontiers in Allergy
- 104 views
740 Publications
Volume 6 - 2025
Original Research
Accepted on 13 Oct 2025
Burden of Allergic Rhinitis in the United Kingdom
Frontiers in Allergy
- 250 views
Original Research
Published on 13 Oct 2025
Use of oral corticosteroids in patients with asthma: how far is clinical practice from the guidelines? Results from surveys of patients and doctors
Frontiers in Allergy
doi 10.3389/falgy.2025.1638304
- 659 views
Clinical Trial
Published on 13 Oct 2025
Nasal saline irrigation with azelastine-fluticasone nasal spray in moderate-to-severe persistent allergic rhinitis: a randomized controlled trial
Frontiers in Allergy
doi 10.3389/falgy.2025.1622510
- 1,359 views
Original Research
Accepted on 10 Oct 2025
Predicting First-Time Anaphylaxis in the Elderly Using Stacked Machine Learning and Population Registers
Frontiers in Allergy
- 266 views
Brief Research Report
Accepted on 07 Oct 2025
Allergen Immunotherapy for the Control of Moderate to Severe Allergic Asthma: An Evidence-based Conjoint Analysis to Define Candidate Patient Profiles in Spain and Portugal
Frontiers in Allergy
- 259 views
Original Research
Accepted on 03 Oct 2025
Impact of Biologic Therapy on Blood Cell Indices and Exacerbation Risk in Severe Asthma: Predictive Value of the Neutrophil-to-Eosinophil Ratio
Frontiers in Allergy
- 290 views
Review
Published on 03 Oct 2025
The roles of serum Th1, Th2, and Th17 cytokines in patients with chronic urticaria: a systematic review and meta-analysis
Frontiers in Allergy
doi 10.3389/falgy.2025.1673041
- 971 views
Case Report
Published on 02 Oct 2025
Case Report: Not all recurrent “idiopathic” anaphylaxis is idiopathic
Frontiers in Allergy
doi 10.3389/falgy.2025.1661992
- 1,010 views
Brief Research Report
Published on 01 Oct 2025
Machine learning–derived genetic risk scores identify IL21 as a predictor of response to omalizumab and dupilumab in asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1670783
- 1,018 views
Original Research
Published on 01 Oct 2025
Pediatric Mycoplasma pneumoniae-induced rash and mucositis in China: clinical spectrum, co-infections and risk factors for recurrence—a retrospective cohort study
Frontiers in Allergy
doi 10.3389/falgy.2025.1646688
- 1,107 views
Review
Published on 30 Sep 2025
The recent advances of mast cells in the pathogenesis of atopic dermatitis
Frontiers in Allergy
doi 10.3389/falgy.2025.1668742
- 1,756 views
Review
Accepted on 29 Sep 2025
Predictors of Response to Omalizumab and Relapse in Chronic Spontaneous Urticaria: A Narrative Review Focusing on Parameters Available in Routine Clinical Practice
Frontiers in Allergy
- 369 views
Review
Published on 29 Sep 2025
Bhopal, Dunsmuir and TRPA1: what they have taught us about nociception
Frontiers in Allergy
doi 10.3389/falgy.2025.1609137
- 762 views
Original Research
Published on 24 Sep 2025
From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1645968
- 1,253 views
Correction
Published on 23 Sep 2025
Correction: Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study
Frontiers in Allergy
doi 10.3389/falgy.2025.1683768
- 1,159 views